![Seul-Ki Lee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Seul-Ki Lee
Algemeen Directeur bij
D&D PHARMATECH INC.
Vermogen: 221 M $ op 31-08-2026
Profiel
Seul-Ki Lee is the founder of Neuraly, Inc. where he holds the title of Chief Executive Officer & Director since 2016.
He is also the founder of D&D Pharmatech Co., Ltd. where he holds the title of CEO, Director, Head-Research & Technology since 2014.
Dr. Lee is also the founder of Theraly Fibrosis, Inc...
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
D&D PHARMATECH CO., LTD. 12,34% | 04-06-2026 | 5.655.524 ( 12,34% ) | 221 M $ | 31-08-2026 |
Actieve functies van Seul-Ki Lee
| Bedrijven | Functie | Begin |
|---|---|---|
| D&D PHARMATECH INC. | Algemeen Directeur | - |
Neuraly, Inc.
 Neuraly, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in physical and biological research | Oprichter | 01-01-2016 |
Theraly Fibrosis, Inc.
 Theraly Fibrosis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Oprichter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
19
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Neuraly, Inc.
Neuraly, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in physical and biological research | Commercial Services |
Theraly Fibrosis, Inc.
Theraly Fibrosis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
D&D Pharma Tech Co., Ltd.
 D&D Pharma Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
